By Jodi Yeats and Karen Sims 31 August 2023 L-R: Prof Marcel Nold, Prof Claudia Nold When baby Blessing arrived at 25 weeks, her parents joined a drug trial they hope will benefit all preterm babies. Already used for inflammatory diseases in older children and adults, the trial focuses on anakinra - a drug neonatal specialists expect to assist preterm babies, given their risk of inflammation. Being cared for at the neonatal unit at Te Whatu Ora Starship Children's Hospital at Te Toka Tumai Auckland by Dr Gergely Toldi, Blessing was her mother's first preterm birth.

https://www.monash.edu/medicine/news/latest/2023-articles/delivering-hope-anti-inflammatory-drug-trial-for-preterm-babies

#monash